baber/WOPTO huggingface dataset:
Patent NZ-288027-A (NZ)
Title: Catalyst comprising finely divided anchor metal partially embedded on an alkali resistant support and partially coated with a catalytically active nonprecious metal; preparation of carboxylic acid salts
Inventor: EBNER JERRY RUDOLPH
IPC: B01J35/10
Filed: 1995-05-26
Abstract: A process to manufacture a carboxylic acid salt is disclosed wherein an aqueous solution of a primary alcohol is contacted with a base hydroxide in the presence of an effective amount of a catalyst consisting essentially of an alkali resistant support, from about 0.05 wt. % to about 10 wt. %, based on the total weight of the catalyst, of an anchor metal is selected from the group consisting of platinum, palladium, ruthenium, and gold, and between about 1 wt. % and about 50 wt. %, based on the total weight of the catalyst, of an element selected from the group consisting of copper, cobalt, nickel, and cadmium combined with the anchor metal.
Patent NZ-316735-A (NZ)
Title: Amino alcohol derivatives of l-n6-(1-iminoethyl) lysine compositions containing these and there use as nitric oxide synthase inhibitors
Inventor: MOORE WILLIAM M
IPC: A61K31/155
Filed: 1996-09-09
Abstract: There is disclosed a novel amino alcohol amine derivatives of L-N6-(1-iminoethyl)lysine, pharmaceutical compositions containing these novel compounds, and to their use in therapy, in particular their use as nitric oxide synthase inhibitors.
Patent NZ-324340-A (NZ)
Title: Method of providing pstn telecommunications services
Inventor: LOW COLIN
IPC: H04L29/12
Filed: 1996-12-11
Abstract: A third-party call setup gateway (90) is provided for setting up bearer channels through a switched telecommunications system, such as a PSTN, by controlling an associated switch (41). The call setup gateway (90) has an interface to the public internet (50). A first user (A) wishing to place a call to a second user (B) sends the call setup gateway (90) both the first user's telephone number (A-telnb) and a personal number (B-Webtel) of the second user. The gateway uses a phone page (49) or a server (51) connected to the Internet (50) to determine the current telephone number for the second user. The gateway then commands the switch to establish a call between the telephones of the first and second users. <IMAGE>
Patent NZ-330944-A (NZ)
Title: Peptide derivatives
Inventor: COTTON RONALD
IPC: C07K14/725
Filed: 1997-02-18
Abstract: The disclosure concerns pharmaceutically useful peptide derivatives of the formula (I): P-R1-R2-R3-R4, in which P, R1, R2, R3, and R4 have the various meanings defined herein, and their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The peptide derivatives are of value in treating MHC class II dependent T-cell mediated autoimmune or inflammatory diseases, such as rheumatoid arthritis. The disclosure further concerns processes for the manufacture of the peptide derivatives and the use of the compounds in medical treatment.
Patent NZ-333168-A (NZ)
Title: Process for preparing 6,7,8,9-tetrahydro-1h-imidazo[4,5-c]quinolin-4-amine derivatives
Inventor: LINDSTROM KYLE J
IPC: C07D471/04
Filed: 1996-10-22
Abstract: A process for preparing 6, 7, 8, 9-tetrahydro-1H-imidazo[4,5-c]quinolin-4-amines is disclosed. The process involves the reduction of a 1H-imidazo[4,5-c]quinolin-4-amine or of a 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline.
Patent NZ-334055-A (NZ)
Title: Electronic ticket data stored in smart cards
Inventor: MULLER FRANK
IPC: G07B15/00
Filed: 1997-08-07
Abstract: The invention relates to tickets on smart cards. According to the invention, tickets (20) comprise several fields: an entitlement field (21), a validation field (22), and preferably also a verification field (23). Data may be written into the said fields (21, 22, 23) in a protected manner using a different key (K1, K2, K3) for each type of field. A further protection of the integrity of the tickets is obtained by using a first storage command (UPDATE) to prepare a field when issuing the ticket and using a different, second storage command (WRITE) when validating the ticket. Preferably, in the tickets a code is used having a fixed number of set bits, thus preventing the fraudulent modification of an issued ticket. <IMAGE>
Patent NZ-336875-A (NZ)
Title: Liner, for a plant container, including one or more sheets of reconstitutable, compressed sphagnum moss
Inventor: TARAWA VARNIE PERRYLEE
IPC: A01G9/02
Filed: 1999-08-11
Abstract: liner 11, for a plant container, comprises a top opening and one or more walls 2 extending in an upstanding configuration towards the opening.  The liner includes one or more sheets of reconstitutable compressed sphagnum moss secured (staples 9) whereby the walls of the liner are self-supporting in the upstanding configuration.  The or each sheet of reconstitutable compressed sphagnum moss may include a water retentive barrier.
Patent NZ-337539-A (NZ)
Title: Coffee grinder comprising one fixed and one rotating grinding wheel
Inventor: KARG ANTON
IPC: A47J42/50
Filed: 1997-03-13
Abstract: Described is a coffee grinder (1).  The grinder has a container for coffee beans, a grinding mechanism (3) with an electric motor and a dispensing and/or braking device for capturing the ground powder (4).  The grinding mechanism has one fixed and one rotating grinding wheel with internal grinding teeth.  The distance between the grinding wheels is adjustable.
Patent NZ-337889-A (NZ)
Title: Cysteine Protease inhibitors of the Papain superfamily comprising cathepsin K protease inhibitors
Inventor: GRIBBLE ANDREW D
IPC: A61K31/341
Filed: 1998-05-06
Abstract: A compound according to formula (I) wherein: R1 is R", R"C(O), R"C(S), R"SO2, R"OC(O), R"R'NC(O), or R"OC(O)NR'CH(R6)C(O); R is H, C1-6alkyl, C2-6alkenyl, Ar-C0-6alkyl, or Het-C0-6alkyl; R is H, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl-C0-6alkyl, Ar-C0-6alkyl, or Het-C0-6alkyl; R4 is H, C1-6alkyl, C2-6alkenyl, Ar-C0-6alkyl, or Het-C0-6alkyl; each R5 independently is H, C1-6alkyl, C2-6alkenyl, Ar-C0-6alkyl, or Het-C0-6alkyl; R6 is H, C1-6alkyl, C2-6alkenyl, C3-6cycloalkyl-C0-6alkyl, Ar-C0-6alkyl, Het-C0-6alkyl; R' is H, C1-6alkyl, C2-6alkenyl, Ar-C0-6alkyl, or Het-C0-6alkyl; R" is C1-6alkyl, Ar-C0-6alkyl, Het-C0-6alkyl, Ar-C2-6alkenyl; or Het-C2-6alkenyl; X is O or S; n is 1,2,or 3; or a pharmaceutically acceptable salt thereof. Also disclosed is the process for the preparation of the above compound and it's use in the treatment of disease in which inhibition of cysteine protease is a factor, inhibition of bone loss, osteoporosis, gingival or periodontal disease, osteoarthritis or rheumatoid arthritis.
Patent NZ-507468-A (NZ)
Title: Method for separating magnetic particles mixed in fluid separating system, and separator
Inventor: KOJIMA HARUO
IPC: B03C1/10
Filed: 1999-04-16
Abstract: A method for separating magnetic particles dispersed in a fluid by magnetic attraction, characterized in that an object fluid in which magnetic particles are dispersed is passed through a magnetized rotary tube, magnetic particles are made to adhere by magnetic attraction to the magnetized surface in the tube, the flow of the fluid is suspended before the capacity of magnetic attraction of the tube lowers, the magnetized surface is demagnetized, an exhaust fluid for exhausting magnetic particles in the tube is made to flow under pressure through the tube, the exhaust fluid mixed with magnetic particles is discharged, and the magnetic particles are separated from the exhaust fluid.
Patent NZ-513724-A (NZ)
Title: Anticonvulsant derivatives useful in treating essential tremor
Inventor: CONNOR GREGORY S
IPC: A61K31/35
Filed: 2000-02-15
Abstract: Described is the use of the compound of the formula I in the manufacture of a medicament for treating or alleviating essential tremor. In the compound of formula I: X is CH2 or oxygen; R1 is hydrogen or C1-C4 alkyl; R2, R3, R4 and R5 are independently hydrogen or C1-C3 alkyl and, when X is CH2, R4 and R5 may be alkene groups joined to form a benzene ring and, when X is oxygen, R2 and R3 and/or R4 and R5 together may be a methylenedioxy group that is optionally substituted on the carbon atom.
Patent NZ-515610-A (NZ)
Title: Method of improving performance of refrigerant systems
Inventor: SCHNUR NICHOLAS E
IPC: C10M171/00
Filed: 2000-06-08
Abstract: A method of improving performance of refrigerant systems such as refrigerators and air conditioners that utilize a refrigerant working fluid. The working fluid consists essentially of a heat transfer fluid and a lubricant that is miscible and is otherwise compatible with the heat transfer fluid at all operating temperatures of the refrigerant system. The method is directed particularly to chlorine-free fluoro-group organic fluids and more particularly to hydrofluorocarbon heat transfer fluids. The preferred lubricants comprise polyol ester basestocks and compounded polyol esters that are highly miscible with such hydrofluorocarbon heat transfer fluids.
Patent NZ-516327-A (NZ)
Title: 25-Cyclohexyl-22,23-dihydro-5-oxoavermectin B1
Inventor: CAMBERS SELENA JANE
IPC: C07D493/22
Filed: 1998-07-23
Abstract: 25-Cyclohexyl-22,23-dihydro-5-oxoavermectin B1.
Patent NZ-519296-A (NZ)
Title: Improved method of handling livestock
Inventor: CRAIG JOHN ROY
IPC: A22B5/08
Filed: 2002-05-31
Abstract: Disclosed is a method of handling an animal immediately before, during and immediately after slaughter.  The method includes the steps: (a) stunning the animal without any preliminary washing or cleaning; (b) removing substantially all of the wool or hair from selected areas of the animal, the selected areas being those where the carcass needs to be cut to complete dressing of the carcass; (c) bleeding the stunned animal either before or after step (b); (d) cutting only through the selected areas of the carcass to complete dressing of the carcass.  Also disclosed is a cutter with which step (d) may be carried out.  The cutter has a shielded blade and a guide tip portion protruding outwards of the blade in the cutting direction.
Patent NZ-521121-A (NZ)
Title: Wireless communication using well casing
Inventor: VINEGAR HAROLD J
IPC: E21B47/12
Filed: 2001-03-02
Abstract: A petroleum well having a borehole extending into a formation is provided. A piping structure is positioned within the borehole, and an induction choke is positioned around the piping structure downhole. A communication system is provided along the piping structure between a surface of the well and the induction choke. A downhole module is positioned on an exterior surface of the piping structure and is configured to measure characteristics of the formation. The formation characteristics, such as pressure and resistivity, are communicated to the surface of the well along the piping structure.
Patent NZ-521425-A (NZ)
Title: Vaccine comprising a first attenuated non-reverting mutant Salmonella in which two or more secretion system apparatus genes have been inactivated
Inventor: LOWERY DAVID E
IPC: A61P31/04
Filed: 2001-03-13
Abstract: Attenuated mutant Salmonella bacteria in which one or more genes homologous to genes within Salmonella pathogenicity island 2(SPI2) have been inactivated are provided for use in safe, efficacious vaccines. Preferably one or more of the secretion system apparatus ssaT, ssaJ, ssaC or ssaM genes, have been inactivated.
Patent NZ-526981-A (NZ)
Title: Auto-injector
Inventor: BERGENS THOMAS
IPC: A61M5/32
Filed: 2001-12-14
Abstract: A device for auto-injection of a dose of medicament, comprising a housing (10) arranged to contain a medicament container (24) therein and comprising a contact part (18, 20) intended to be applied against an injection site, a needle cover (18, 20) surrounding a needle arranged to the medicament container and extending at least the length of the needle, spring means (76, 82) capable of, upon activation, pushing the needle past the end (20) of the needle cover as well as operating the medicament container to supply the dose of medicament, first locking means (46, 58, 62, 78) capable of locking the spring means in a pressurised state, first activating means (54, 58) capable of, upon manual operation, releasing the spring means for injection. A second locking means (56, 68, 70) is capable of locking the first activating means and a second activating means (16, 18, 46) is capable of releasing the second locking means when the contact part is exposed to pressure.
Patent NZ-535639-A (NZ)
Title: Power take off assembly, drive assembly and saw using power take off assembly
Inventor: BARATTA ANTHONY
IPC: B23D47/12
Filed: 2003-03-14
Abstract: A power takeoff assembly for a pavement saw includes an output shaft (82) from a motor, which extends from the endplate of the motor within a hollow, cylindrical supporting element (110). At the end of the shaft, a pulley (112) is coupled such that the pulley rotates on the supporting element, supported by bearings (116, 118).
Patent NZ-537940-A (NZ)
Title: Bi-fold door assembly
Inventor: LLOYD ROSS
IPC: E06B3/48
Filed: 2005-01-28
Abstract: A bi-fold door assembly has a sill 5 and two door panels that are bi-foldable. The sill 5 has a track 15 provided in a cavity 19 below an upper surface of the sill 5. The track 15 receives a weight bearing surface 23 supporting at least one of the door panels. During opening or closing of the doors, the weight of at least one door panel is carried wholly within said track and below an upper surface of the sill 5. When the doors are in a closed condition, the track 15 is wholly under the door panels.
Patent NZ-537951-A (NZ)
Title: Using electrospun polymer nanofibers in amorphous pharmaceutical compositions
Inventor: IGNATIOUS FRANCIS
IPC: A61K47/12
Filed: 2003-08-07
Abstract: A process of making polymer nanofibers from either a solution or melt under electrical forces, to prepare stable, solid dispersions of amorphous drugs in polymer nanofibers is disclosed. Particularly disclosed is a process for making a stable formulation of an amphorous form of a pharmaceutically active agent, which comprises: (a) making a solution of the active agent, and a pharmaceutically acceptable polymeric carrier with a pharmaceutically acceptable solvent; and (b) electrospinning the solution of step (a) into an electrospun fiber. A pharmaceutical composition comprising an electrospun fiber of a pharmaceutically acceptable polymeric carrier homogeneously integrated with a stable amorphous form of a pharmaceutically acceptable active agent is also disclosed.
Patent NZ-540601-A (NZ)
Title: Insulating foam sections
Inventor: TOTTEY JOHN
IPC: B29C44/32
Filed: 2003-12-12
Abstract: A pipe insulating section (1) comprises a generally cylindrical hollow phenolic foam body (2) of substantially uniform cross section with an inner facing web (3) and an outer facing web (4). The phenolic foam body is slit longitudinally to provide section halves which can be opened to facilitate wrapping around a pipe to insulate the pipe. The section halves are linked by the outer web at one side and facing ends of the section halves at the other end are faced with the inner facing web. The inner web may be of paper and the other web may be of an aluminum foil. An apparatus used in manufacturing the elongate shaped phenolic section comprises an outer mould (10) for forming the outer facing (4) into a cylindrical shape and an inner mandrel (11) for forming the inner facing (3) into a cylindrical shape, which is of smaller diameter than that of the cylinder defined by the outer facing. The facings define a hollow core therebetween into which liquid foam reactants (20) are injected through an injector (25).
Patent NZ-540766-A (NZ)
Title: Screen mounted in surrounding frame assembly
Inventor: VEIVERS BRADLEY MARK
Filed: 2005-06-15
Abstract: A screen assembly for particular use as an insect screen or security screen is disclosed. A sheet of screen material 19 is mounted in a frame assembly 10 that is made up of a number of channel sections 11. A peripheral edge 18 of the screen is secured in the channel by being sandwiched between a first strip 15 and a second locking strip 24. The first strip is located against a side wall of the channel using co-operating location means 20, 21, 22, 23. The locking strip is inserted in place after the edge of the screen is located in position adjacent the first strip.
Patent NZ-542505-A (NZ)
Title: Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy
Inventor: GRIND MARGARETHA
IPC: A61K31/397
Filed: 2004-03-19
Abstract: Disclosed is the use of a thrombin inhibitor of formula I, wherein Ra represents -OH or CH2OH; and the rest of the substituents are disclosed within the specification; or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for use in cholesterol-lowering therapy. Also disclosed is the above use wherein the pharmaceutically acceptable derivative of formula I is the prodrug of formula Ia wherein the substituents are disclosed within the specification.
Patent NZ-543753-A (NZ)
Title: Thermal processes for subsurface formations
Inventor: VINEGAR HAROLD J
IPC: E21B43/24
Filed: 2004-04-23
Abstract: A subsurface heating system configured to heat a hydrocarbon containing formation is described. The system comprises: a heater well extending from a surface of the earth into the hydrocarbon containing formation; and one or more electrical conductors configured to be placed in the heater well, at least one of the conductors extending from the surface into the hydrocarbon containing formation. At least one electrical conductor has an electrically resistive portion configured to provide a heat output when an alternating current is applied through the electrically resistive portion. At least one of the electrically resistive portions is configured to provide a reduced heat output that is about 20% or less of the heat output provided at about 50° below the selected temperature when above or near a selected temperature. The system is configured to provide heat to the hydrocarbon containing formation such that sufficient heat transfers from at least one of the electrical conductors to hydrocarbons in the hydrocarbon containing formation to at least mobilize some hydrocarbons in the formation.
Patent NZ-543832-A (NZ)
Title: Profiled rail and method for producing a profiled rail
Inventor: MAISCH CHRISTOF
IPC: H01L27/108
Filed: 2004-05-28
Abstract: The disclosure relates to a profiled rail for supporting plate-shaped elements, particularly for inlay mounting of ceiling plates for louvered ceilings. The profiled rail comprises a base body, which is provided, at least in areas with a T-profile and which has a longitudinally extended web as well as a lower flange. The lower flange is placed along a longitudinal edge of the web and comprises two lower flange sections each extending from the web essentially in opposite directions. The lower flange is formed by bending the web, and the side of the lower flange, which is oriented away from the web, is provided with a facing board. A multitude of openings are provided in the web, whereby at least one of the lower flange sections is formed by material sections of the web that are folded out from the openings, and the web is provided as a single layer essentially over its entire surface. The invention also relates to a method for producing a profiled rail of this type.
Patent NZ-546067-A (NZ)
Title: Morpholine derivatives such as 2-[5-fluoro-2-methyloxy)phenyl]-1-morpholin-2-yl-1-tetrahydro-2H-pyran-4-ylethanol as norepinephrine reuptake inhibitors
Inventor: CAMPBELL GORDON IAIN
IPC: A61K31/535
Filed: 2004-10-28
Abstract: Disclosed is a compound of formula (I), or pharmaceutically acceptable salts thereof. Also disclosed is the suitability of the above compound for treating ADHD, cognitive disorder, depression, oppositional defiant disorder, hot flashes, and vasomotor symptons.
Patent NZ-548990-A (NZ)
Title: Anti-CD38 human antibodies and uses therefor
Inventor: TESAR MICHAEL
IPC: C07K16/28
Filed: 2005-02-07
Abstract: Disclosed is an isolated human or humanized antibody or functional fragment thereof comprising an antigen-binding region that is specific for an epitope of CD38(SEQ ID NO: 22), wherein said antibody or functional fragment thereof is able to mediate killing of a CD38+ target cell by ADCC with an at least five-fold better efficacy than chimeric OKT10 (SEQ ID NOs: 23 and 24) under the same or substantially the same conditions when a human PBMC cell is employed as an effector cell, wherein said CD38+ target cell is selected from the group consisting of LP-1 (DSMZ: ACC41) and RPMI-8226 (ATCC: CCL-155), and wherein the ratio of effector cells to target cells is between about 30:1 and about 50:1.
Patent NZ-555486-A (NZ)
Title: Preparation of hydrocarbons through a liquid phase oxidative desulphurisation process utilising a solid titanium catalyst
Inventor: KECKLER KENNETH P
IPC: B01J21/06
Filed: 2005-12-22
Abstract: Disclosed is a liquid phase process for desulphurising a distillate feedstock to produce refinery transportation fuel or blending components for refinery transportation fuel wherein the feedstock contains sulphur-containing organic impurities, which process comprises: (a) contacting the feedstock in the liquid phase with an oxygen containing gas in an oxidation/adsorption zone at oxidation conditions in the presence of a solid oxidation catalyst comprising a titanium-containing composition to convert at least a portion of the sulphur-containing organic impurities to sulphones and/or sulphoxides; (b) adsorbing the sulphones and/or sulphoxides on the solid oxidation catalyst; (c) recovering an oxidation/adsorption zone liquid effluent having a reduced amount of sulphur-containing impurities; and (d) removing the adsorbed sulphones and/or sulphoxides from the oxidation catalyst to regenerate the oxidation catalyst.
Patent NZ-555563-A (NZ)
Title: 2-methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol
Inventor: DELUCA HECTOR F
Filed: 2005-11-18
Abstract: Disclosed are vitamin D compounds, particularly 2-methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol and pharmaceutical formulations that include this compound. The invention also relates to the use of 2-methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol or salts thereof in the preparation of medicaments for use in treating various diseases.
Patent NZ-560327-A (NZ)
Title: Compositions and methods for less immunogenic protein formulations
Inventor: PUROHIT VIVEK S
IPC: A61K35/14
Filed: 2006-02-02
Abstract: Provided is a method for reducing the immunogenicity of a therapeutic agent selected from the group consisting of peptide, polypeptide and protein comprising the steps of forming a lipid complex of the therapeutic agent with a binding agent, wherein the binding agent is O-phospho-L-serine, and wherein the immunogenicity of the therapeutic agent is reduced when complexed with the binding agent. The therapeutic agent can be Factor VIII.
Patent NZ-563781-A (NZ)
Title: Pyripyropene derivatives having insecticidal activity for controlling pests
Inventor: GOTO KIMIHIKO
IPC: A01N43/90
Filed: 2006-05-31
Abstract: Disclosed is a use of a compound represented by formula (I) or an agriculturally and horticulturally acceptable salt thereof as a pest control agent particularly for controlling hemipteran pests selected from the group consisting of Myzus persicae, Aphis gossypii, Aphis fabae, Aphis maidis (corn-leaf aphid), Acyrthosiphon pisum, Aulacorthum solani, Aphis craccivora, Macrosiphum euphorbiae, Macrosiphum avenae, Metopolophium dirhodum, Rhopalosiphum padi, Schizaphis graminum, Brevicoryne brassicae, Lipaphis erysimi, Aphis citricola, Rosy apple aphid, Eriosoma lanigerum, Toxoptera aurantii, Toxoptera citricidus, and Pseudococcus comstocki.